Etesian Wealth Advisors’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$301K Sell
2,054
-38
-2% -$5.53K 0.09% 115
2026
Q1
$302K Buy
2,092
+165
+9% +$25K 0.1% 111
2025
Q4
$276K Hold
1,927
0.09% 117
2025
Q3
$296K Sell
1,927
-77
-4% -$12K 0.1% 115
2025
Q2
$319K Sell
2,004
-550
-22% -$89.8K 0.12% 111
2025
Q1
$435K Sell
2,554
-507
-17% -$84.9K 0.19% 100
2024
Q4
$513K Sell
3,061
-702
-19% -$120K 0.23% 98
2024
Q3
$652K Sell
3,763
-757
-17% -$129K 0.3% 87
2024
Q2
$745K Sell
4,520
-355
-7% -$58K 0.42% 75
2024
Q1
$791K Sell
4,875
-65
-1% -$10.2K 0.45% 68
2023
Q4
$720K Sell
4,940
-90
-2% -$13.3K 0.43% 69
2023
Q3
$734K Sell
5,030
-704
-12% -$108K 0.49% 67
2023
Q2
$870K Sell
5,734
-11
-0.2% -$1.66K 0.57% 59
2023
Q1
$854K Buy
5,745
+102
+2% +$14.6K 0.57% 59
2022
Q4
$855K Buy
+5,643
New +$791K 0.62% 57

Other funds holding PG

Etesian Wealth Advisors's PG Position: Q2 2026 in Review

Etesian Wealth Advisors reduced its Procter & Gamble (PG) stake by 1.8% in Q2 2026, selling an estimated $5.53K and leaving 2,054 shares worth $301K. The position accounts for 0.09% of the portfolio, ranked #115.

Etesian Wealth Advisors first reported a position in PG in Q4 2022 and has held it in 15 quarters since. The position peaked at $870K in Q2 2023. 4,020 funds tracked by Wall St. Rank hold PG as of Q2 2026.

  • Etesian Wealth Advisors held 2,054 shares of Procter & Gamble worth $301K as of Q2 2026.
  • Etesian Wealth Advisors sold 38 Procter & Gamble shares in Q2 2026, an estimated $5.53K.
  • Procter & Gamble made up 0.09% of Etesian Wealth Advisors's portfolio in Q2 2026, its #115 holding.
  • Etesian Wealth Advisors first reported a position in Procter & Gamble in Q4 2022 and has held it in 15 quarters since.
  • Etesian Wealth Advisors's Procter & Gamble position peaked at $870K in Q2 2023.
  • 4,020 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on Etesian Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.